These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 412844)

  • 21. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on drug-induced lipidosis. VI. Identification and determination of the drug and its metabolite in lipidosis induced by 4,4'-diethylaminoethoxyhexestrol.
    Matsuzawa Y; Yokomura T; Ishikawa K; Adachi S; Yamamoto A
    J Biochem; 1972 Sep; 72(3):615-21. PubMed ID: 4634972
    [No Abstract]   [Full Text] [Related]  

  • 24. [14 cases of drug-induced lipidosis--with special reference autopsy cases].
    Oda M; Furuta S; Omori M; Takayama H; Hanaoka Y
    Saishin Igaku; 1971 Nov; 26(11):2236-40. PubMed ID: 5141964
    [No Abstract]   [Full Text] [Related]  

  • 25. [A case of drug-induced lipidosis with "sea-blue histiocytes" in the bone marrow].
    Imoto S; Hiraide S; Mitsutani S; Matsumoto H; Kaneko S
    Naika Hokan; 1971; 18(3):83-108. PubMed ID: 4935924
    [No Abstract]   [Full Text] [Related]  

  • 26. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat.
    Sgaragli GP; Della Corte L; Gremigni D
    Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chlorocyclizine on pulmonary lipid metabolism in rats.
    Stern N; Tietz A; Gaton E; Wolman M
    Biochim Biophys Acta; 1983 Nov; 754(2):166-73. PubMed ID: 6140029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatic lipidosis in the lactating rat fed a low protein and methionine supplemented diet: comparison of effects of fructose and glucose].
    Leclerc J; Miller ML
    C R Seances Acad Sci III; 1982 Oct; 295(5):389-92. PubMed ID: 6817876
    [No Abstract]   [Full Text] [Related]  

  • 31. An immunohistochemical approach to differentiate hepatic lipidosis from hepatic phospholipidosis in rats.
    Obert LA; Sobocinski GP; Bobrowski WF; Metz AL; Rolsma MD; Altrogge DM; Dunstan RW
    Toxicol Pathol; 2007 Aug; 35(5):728-34. PubMed ID: 17763287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats.
    Junnila M; Barak AJ; Beckenhauer HC; Rahko T
    Vet Hum Toxicol; 1998 Oct; 40(5):263-6. PubMed ID: 9778759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of Chinese prescription Kangen-karyu and its crude drug Tanjin against age-related lipidosis in rats.
    Cho EJ; Yokozawa T; Okamoto T
    J Pharm Pharmacol; 2007 May; 59(5):687-94. PubMed ID: 17524234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of myelin-like figures induced by diazafluoranthen derivative. A possible experimental model.
    Hildebrand J; Thys O
    Acta Neurol Belg; 1973; 73(6):359-61. PubMed ID: 4791820
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outline of a specific disease caused by diethylaminoethoxyhexestrol (DH)].
    Nishikawa M
    Saishin Igaku; 1971 Nov; 26(11):2206-9. PubMed ID: 5141957
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-pathological studies on 7 cases suspected to have phospholipidosis and epidemiological studies on 116 cases given diethylaminoethoxyhexestrol(DH)].
    Sasaki H; Tanaka S; Kimura K; Ichida F
    Saishin Igaku; 1971 Nov; 26(11):2230-6. PubMed ID: 5141963
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of lipoprotein metabolic disorders during treatment with oral contraceptives].
    Titov VN; Sanfirova VM; Khodakova TD
    Farmakol Toksikol; 1980; 43(3):345-8. PubMed ID: 7449976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human accumulation potential of xenobiotics: potential of catamphiphilic drugs to promote their accumulation via inducing lipidosis or mucopolysaccharidosis.
    Hein L; Lüllmann-Rauch R; Mohr K
    Xenobiotica; 1990 Nov; 20(11):1259-67. PubMed ID: 2125772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secondary phospholipidosis caused by 4.4'-diethylaminoethoxy hexestrol].
    Shikata T
    Rinsho Byori; 1973 May; 21(5):389-94. PubMed ID: 4738035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.